HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characteristics associated with successful weaning in ventilator-dependent preterm infants.

Abstract
Eighteen ventilator-dependent preterm infants with hyaline membrane disease were studied for 24 hours before and after an attempt at extubation. All were treated with theophylline prior to weaning and achieved average levels of 8.9 +/- 1.7 micrograms/ml (49 +/- 9 mumol/liter) in 13 successfully weaned infants and 8.4 +/- 1.1 micrograms/ml (47 +/- 6 mumol/liter) in 5 infants not extubated, p > 0.05. Infants successfully weaned were significantly (p < 0.01) older, more mature (29 +/- 1 versus 26 +/- 2 weeks' gestational age) and heavier (1107 +/- 236 versus 1016 +/- 256 gm) than infants not successfully extubated. Infants successfully weaned differed only in developing a greater maximal inspiratory force (33.8 +/- 12.3 versus 23.3 +/- 15.0 cm H2O) and higher compliance (1.1 +/- 0.3 versus 0.7 +/- 0.3) during the preweaning treatment period. These results indicate that maturity and size play a significant role in the ability to wean a preterm infant from the ventilator successfully, that maximal inspiratory force and compliance are higher in preterm infants who can be successfully extubated, and that methylxanthines do not uniformly improve pulmonary function in all potentially extubatable preterm infants.
AuthorsE M Sillos, M Veber, M Schulman, A N Krauss, P A Auld
JournalAmerican journal of perinatology (Am J Perinatol) 1992 Sep-Nov Vol. 9 Issue 5-6 Pg. 374-7 ISSN: 0735-1631 [Print] United States
PMID1418137 (Publication Type: Journal Article)
Chemical References
  • Theophylline
Topics
  • Humans
  • Hyaline Membrane Disease (therapy)
  • Infant
  • Infant, Newborn
  • Inspiratory Capacity
  • Intubation, Intratracheal
  • Lung Compliance
  • Theophylline (therapeutic use)
  • Time Factors
  • Ventilator Weaning

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: